Your prediction
Matthews International Corp. Stock
Pros and Cons of Matthews International Corp. in the next few years
Pros
Cons
Performance of Matthews International Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Matthews International Corp. | 0.000% | -0.826% | 3.448% | 20.060% | 6.667% | -42.029% | -17.241% |
| Vuzix Corp. | 4.300% | -0.049% | -17.279% | 21.476% | -32.229% | -56.777% | -83.761% |
| USANA Health Sciences Inc. | 2.170% | 0.546% | 0.000% | -27.559% | 11.515% | -68.276% | -77.284% |
| Pola Orbis Holdings Inc. | 0.000% | 2.899% | 5.970% | -2.740% | 2.158% | -39.831% | -63.959% |
Comments
News
Eton Pharmaceuticals Q1 Earnings Call Highlights
Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?
According to its SEC filing dated May 4, 2026, Matthews International Capital Management LLC purchased 242,785 additional shares of Yum China (NYSE:YUMC) in the first quarter.
The estimated value of


